• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕洛诺司琼与格拉司琼用于防治术后恶心呕吐的随机双盲前瞻性研究。

Palonosetron and granisetron in postoperative nausea vomiting: A randomized double-blind prospective study.

作者信息

Gugale Amrita A, Bhalerao Pradnya Milind

机构信息

Department of Anaesthesiology and Critical Care, B. J. Government Medical College and Sassoon General Hospital, Pune, Maharashtra, India.

出版信息

Anesth Essays Res. 2016 Sep-Dec;10(3):402-407. doi: 10.4103/0259-1162.191121.

DOI:10.4103/0259-1162.191121
PMID:27746523
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5062237/
Abstract

BACKGROUND

Postoperative nausea and vomiting (PONV) is a common occurrence after laparoscopic surgeries. A number of pharmacological agents (antihistamines, butyrophenones, dopamine receptor antagonists) have been tried of which the 5-hydroxytryptamine type 3 receptor antagonists are devoid of most side effects and highly effective in prevention and treatment of PONV. Thus, we evaluated the effectiveness of granisetron and palonosetron in prevention of PONV after laparoscopic surgeries under general anesthesia.

AIMS

We conducted a study to evaluate the effectiveness of granisetron and palonosetron, to compare the duration of action and side effects if any, in patients undergoing elective laparoscopic surgery under general anesthesia.

SETTINGS AND DESIGN

This was a prospective, randomized, double-blinded, comparative study. Sixty patients (18-65 years of age) of the American Society of Anesthesiologists Grade I and II undergoing elective laparoscopic surgeries were considered.

MATERIALS AND METHODS

They were randomly allocated into one of the two groups (Group G and Group P) of thirty patients each. Group G received injection granisetron 0.05 mg/kg; Group P received injection palonosetron 1.5 mcg/kg intravenous bolus 30 min before the induction of anesthesia.

STATISTICAL TESTS

All statistical analyses were performed using the SPSS statistical package version 18.0 (Chicago: SPSS Inc). Two independent sample -test was used for quantitative data, and the χ or Fisher's exact test was used for qualitative data. A difference was regarded as statistically significant at a < 0.05.

RESULTS

The need for rescue antiemetic was significantly lower in Group P in the 24-72 h postoperative period (ρ - 0.007). The PONV score was significantly less in Group P in the same period (ρ - 0.008). The incidence of side effects was statistically insignificant in both the groups (ρ - 0.999).

CONCLUSION

Prophylactic therapy with palonosetron is more effective than granisetron in the prevention of PONV after laparoscopic surgeries under general anesthesia.

摘要

背景

术后恶心呕吐(PONV)是腹腔镜手术后的常见情况。已经尝试了多种药物(抗组胺药、丁酰苯类、多巴胺受体拮抗剂),其中5-羟色胺3型受体拮抗剂副作用最少,在预防和治疗PONV方面非常有效。因此,我们评估了格拉司琼和帕洛诺司琼在全身麻醉下腹腔镜手术后预防PONV的有效性。

目的

我们进行了一项研究,以评估格拉司琼和帕洛诺司琼的有效性,比较在全身麻醉下接受择期腹腔镜手术患者的作用持续时间和副作用(如有)。

设置与设计

这是一项前瞻性、随机、双盲、对照研究。纳入60例年龄在18 - 65岁、美国麻醉医师协会分级为I级和II级的择期腹腔镜手术患者。

材料与方法

他们被随机分为两组(G组和P组),每组30例。G组接受0.05 mg/kg格拉司琼注射液;P组在麻醉诱导前30分钟接受1.5 mcg/kg帕洛诺司琼注射液静脉推注。

统计分析

所有统计分析均使用SPSS统计软件包18.0版(芝加哥:SPSS公司)进行。定量数据采用两独立样本t检验,定性数据采用χ²检验或Fisher精确检验。P < 0.05被认为具有统计学意义。

结果

术后24 - 72小时,P组需要补救性使用止吐药的情况显著低于G组(P = 0.007)。同一时期,P组的PONV评分显著低于G组(P = 0.008)。两组副作用发生率在统计学上无显著差异(P = 0.999)。

结论

在全身麻醉下腹腔镜手术后预防PONV方面,帕洛诺司琼预防性治疗比格拉司琼更有效。

相似文献

1
Palonosetron and granisetron in postoperative nausea vomiting: A randomized double-blind prospective study.帕洛诺司琼与格拉司琼用于防治术后恶心呕吐的随机双盲前瞻性研究。
Anesth Essays Res. 2016 Sep-Dec;10(3):402-407. doi: 10.4103/0259-1162.191121.
2
Comparison of Palonosetron with Granisetron for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Abdominal Surgery.帕洛诺司琼与格拉司琼预防腹腔镜腹部手术患者术后恶心呕吐的比较。
Anesth Essays Res. 2018 Jul-Sep;12(3):636-643. doi: 10.4103/aer.AER_84_18.
3
A comparative study between palonosetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy.帕洛诺司琼与格拉司琼预防腹腔镜胆囊切除术后恶心呕吐的比较研究。
J Anaesthesiol Clin Pharmacol. 2010 Oct;26(4):480-3.
4
Postoperative Nausea and Vomiting Prophylaxis: A Comparative Study of Ramosetron and Palonosetron in Patients Undergoing Laparoscopic Cholecystectomy - A Prospective Randomized Trial.术后恶心呕吐的预防:雷莫司琼与帕洛诺司琼用于腹腔镜胆囊切除术患者的比较研究——一项前瞻性随机试验
Anesth Essays Res. 2019 Jan-Mar;13(1):68-72. doi: 10.4103/aer.AER_192_18.
5
Palonosetron, Ondansetron, and Granisetron for antiemetic prophylaxis of postoperative nausea and vomiting - A comparative evaluation.帕洛诺司琼、昂丹司琼和格拉司琼用于术后恶心和呕吐的预防性止吐——一项比较评估。
Anesth Essays Res. 2014 May-Aug;8(2):197-201. doi: 10.4103/0259-1162.134503.
6
A Randomised Study To Compare Palonosetron With Ondansetron for Prophylaxis of Postoperative Nausea and Vomiting (PONV) Following Laparoscopic Gynecological Surgeries.一项比较帕洛诺司琼与昂丹司琼预防腹腔镜妇科手术后恶心和呕吐(PONV)的随机研究。
Cureus. 2022 Mar 29;14(3):e23615. doi: 10.7759/cureus.23615. eCollection 2022 Mar.
7
Comparison of palonosetron, granisetron, and ramosetron for the prevention of postoperative nausea and vomiting after laparoscopic gynecologic surgery: a prospective randomized trial.帕洛诺司琼、格拉司琼和雷莫司琼预防腹腔镜妇科手术后恶心呕吐的比较:一项前瞻性随机试验。
BMC Anesthesiol. 2015 Sep 3;15:121. doi: 10.1186/s12871-015-0102-0.
8
Efficacy of palonosetron in postoperative nausea and vomiting (PONV)-a meta-analysis.帕洛诺司琼治疗术后恶心呕吐(PONV)的疗效:一项荟萃分析。
J Clin Anesth. 2016 Nov;34:459-82. doi: 10.1016/j.jclinane.2016.05.018. Epub 2016 Jun 28.
9
A randomized, double-blind trial evaluating the efficacy of palonosetron with total intravenous anesthesia using propofol and remifentanil for the prevention of postoperative nausea and vomiting after gynecologic surgery.一项随机双盲试验,评估帕洛诺司琼联合丙泊酚和瑞芬太尼全静脉麻醉用于预防妇科手术后恶心呕吐的疗效。
J Anesth. 2016 Dec;30(6):935-940. doi: 10.1007/s00540-016-2249-3. Epub 2016 Sep 20.
10
Efficacy of Palonosetron as Antiemetic Prophylaxis for Post Operative Patients.帕洛诺司琼作为术后患者预防性止吐药的疗效
Mymensingh Med J. 2019 Jan;28(1):222-229.

引用本文的文献

1
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
2
Comparison of Palonosetron with Granisetron for Prevention of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Abdominal Surgery.帕洛诺司琼与格拉司琼预防腹腔镜腹部手术患者术后恶心呕吐的比较。
Anesth Essays Res. 2018 Jul-Sep;12(3):636-643. doi: 10.4103/aer.AER_84_18.

本文引用的文献

1
Palonosetron, Ondansetron, and Granisetron for antiemetic prophylaxis of postoperative nausea and vomiting - A comparative evaluation.帕洛诺司琼、昂丹司琼和格拉司琼用于术后恶心和呕吐的预防性止吐——一项比较评估。
Anesth Essays Res. 2014 May-Aug;8(2):197-201. doi: 10.4103/0259-1162.134503.
2
Palonosetron and palonosetron plus dexamethasone to prevent postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: A prospective, randomized, double-blind comparative study.帕洛诺司琼及帕洛诺司琼联合地塞米松预防腹腔镜胆囊切除术后恶心呕吐:一项前瞻性、随机、双盲对照研究。
Anesth Essays Res. 2011 Jul-Dec;5(2):134-7. doi: 10.4103/0259-1162.94751.
3
A comparative study between palonosetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy.
帕洛诺司琼与格拉司琼预防腹腔镜胆囊切除术后恶心呕吐的比较研究。
J Anaesthesiol Clin Pharmacol. 2010 Oct;26(4):480-3.
4
Different doses of palonosetron for the prevention of postoperative nausea and vomiting in children undergoing strabismus surgery.不同剂量帕洛诺司琼预防斜视手术患儿术后恶心呕吐。
Drugs R D. 2011;11(1):29-36. doi: 10.2165/11586940-000000000-00000.
5
Risk factors for severe postoperative nausea and vomiting in a randomized trial of nitrous oxide-based vs nitrous oxide-free anaesthesia.在一项基于氧化亚氮与无氧化亚氮麻醉的随机试验中,术后严重恶心呕吐的危险因素。
Br J Anaesth. 2008 Oct;101(4):498-505. doi: 10.1093/bja/aen230. Epub 2008 Aug 5.
6
Palonosetron exhibits unique molecular interactions with the 5-HT3 receptor.帕洛诺司琼与5-羟色胺3(5-HT3)受体表现出独特的分子相互作用。
Anesth Analg. 2008 Aug;107(2):469-78. doi: 10.1213/ane.0b013e318172fa74.
7
A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo for preventing postoperative nausea and vomiting.一项随机、双盲研究,旨在评估三种不同剂量的帕洛诺司琼与安慰剂预防术后恶心和呕吐的疗效及安全性。
Anesth Analg. 2008 Aug;107(2):445-51. doi: 10.1213/ane.0b013e31817b5ebb.
8
A randomized, double-blind study to evaluate the efficacy and safety of three different doses of palonosetron versus placebo in preventing postoperative nausea and vomiting over a 72-hour period.一项随机、双盲研究,旨在评估三种不同剂量的帕洛诺司琼与安慰剂在预防72小时内术后恶心和呕吐方面的疗效和安全性。
Anesth Analg. 2008 Aug;107(2):439-44. doi: 10.1213/ane.0b013e31817abcd3.
9
Pharmacology, pharmacogenetics, and clinical efficacy of 5-hydroxytryptamine type 3 receptor antagonists for postoperative nausea and vomiting.5-羟色胺3型受体拮抗剂用于术后恶心和呕吐的药理学、药物遗传学及临床疗效
Curr Opin Anaesthesiol. 2006 Dec;19(6):606-11. doi: 10.1097/01.aco.0000247340.61815.38.
10
Risk factors for postoperative nausea and vomiting.术后恶心呕吐的危险因素。
Anesth Analg. 2006 Jun;102(6):1884-98. doi: 10.1213/01.ANE.0000219597.16143.4D.